Clarivate

OCTOBER 25, 2021

The move further expands and integrates drug toxicity data and translational safety intelligence from OFF-X into all aspects of the life science cycle.

Safety 110

Safety Biopharma Competition Management 110

European Pharmaceutical Review

DECEMBER 19, 2022

3 Under this pathway, comparability studies are required to substantiate the similar nature, in terms of safety and efficacy, of the biosimilar and the reference product. Chris was named a ‘Rising Star’ in the 2022 Legal 500 Rankings for Life Sciences and Healthcare. References/Endnotes. Biosimilars in the EU.

Medicine 52

Medicine Biopharma Safety Food 52

pharmaphorum

SEPTEMBER 20, 2022

The phase 1/3 ROSALIA study showed that the copycat denosumab matched Amgen’s brand on multiple pharmacokinetics, pharmacodynamics, efficacy, safety, and immunogenicity measures in postmenopausal women with osteoporosis, said Sandoz in a statement. billion TNF inhibitor Enbrel (etanercept) and $2.25

Medicine 52

Medicine Safety Marketing Biopharma 52

Clarivate

OCTOBER 25, 2023

Expect some provider practices to research using alternative treatments not subject to price negotiations for their new patients, assuming comparable efficacy, safety, and tolerability (e.g., Providers therefore could find their buy and bill operations are in the red.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharma Marketing Network

MARCH 25, 2022

With an estimated 65 million people serving as caregivers, 1 the role is now a factor in an ever-increasing list of healthcare priorities. If caregiving is positioned as an essential service and caregivers are counted among healthcare’s front-line service providers, 4 does it follow caregivers are a viable healthcare vertical?

Pharma 98

Pharma Education Transportation Training 98

Pharmaceutical Technology

SEPTEMBER 8, 2022

The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Patient monitoring for safety and efficacy. Dispensing of speciality pharmaceuticals and shipping coordination. Prescription refill and renewal.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharmaceutical Technology

NOVEMBER 4, 2022

The expertise in procurement for new projects is a definite advantage with choosing a CMO like Baxter BioPharma Solutions. While the industry learned a lot from the impact of COVID - particularly when it comes to agility – it is impossible to predict when a new wave of challenges will next emerge.

Biopharma 52

Biopharma Manufacturing Media Pharmaceutical 52

PM360

DECEMBER 14, 2023

We’re now leveraging our expertise in communicating with healthcare professionals to deliver essential information and practical tools to physicians and other healthcare providers to help them address the challenges faced by patients with chronic illness.”

Physicians 52

Physicians Pharma Medical Patients 52

European Pharmaceutical Review

DECEMBER 21, 2022

Despite the tidal wave of renewed interest in psychedelic therapies, there is still much to be learned about them, including their precise mechanisms of action, their long- and short-term safety profiles, the durability of their effect, and their adverse effects—which can be severe. Medicines and Healthcare products Regulatory Agency.

Food and Drug Administration 108

Food and Drug Administration Medicine Food Government 108

Clarivate

FEBRUARY 28, 2024

Data from a rising tide of sources can empower pharma executive decision making from R&D, clinical studies, health outcomes, drug safety, and market access. CDISC standards cover various aspects of clinical research data, including study design, data collection, data representation, and data exchange.

Electronics 59

Electronics Healthcare Healthcare Medicine 59

Pharmaceutical Technology

JULY 7, 2022

There is a lot of excitement that we could be at the start of a new era for the biopharmaceutical industry, with the hope of delivering revolutionary healthcare for previously unaddressed diseases finally becoming a reality.

Medicine 98

Medicine Transportation Manufacturing Biopharma 98

Clarivate

NOVEMBER 13, 2023

The purpose of clinical trials is to understand the efficacy and safety of treatments for the patients who need them. Last year alone the Clarivate COA team conducted over 300 interviews with patients, caregivers or healthcare professionals. The PFDD series will eventually take the place of the PRO Guidance for Industry.

Patients 52

Patients Food and Drug Administration FDA Safety 52

PM360

SEPTEMBER 15, 2022

But battling information asymmetry is one of the best ways to address the ongoing inequities in our healthcare system. But to shift the industry’s approach to healthcare, all stakeholders must move the efforts, attention, and education necessary to find a common ground and ensure that the patients’ interests are always driving development.

Patients 98

Patients Healthcare Healthcare Marketing 98

Clarivate

MARCH 14, 2024

Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt. Future research could focus on developing PFAS-free packaging materials that meet regulatory standards without compromising safety. Impending change affords an opportunity for innovation.

Pharmaceutical 52

Pharmaceutical Manufacturing Food Healthcare Provider 52

European Pharmaceutical Review

FEBRUARY 21, 2023

Crucially, January 2023 marked a key moment: the Medicines and Healthcare products Regulatory Agency (MHRA) granted Celadon Pharmaceuticals the first good manufacturing practice (GMP) registration since legalisation in 2018 for high Δ9-tetrahydrocannabinol (THC) cannabis active pharmaceutical ingredient (API).

Medicine 129

Medicine Manufacturing Specialization Pharmaceutical 129

Clarivate

OCTOBER 19, 2023

Drug candidates have a high rate of failure, as only 10% of de-novo drugs put through clinical trials finally obtain market approval, with the highest rate of attrition occurring at phase I and II of clinical trials (assessing safety, tolerability, dosage, efficacy, and side effects).

Networking 59

Networking Consulting Safety Side effects 59

Pharmaceutical Technology

JANUARY 31, 2023

FDA director Robert Califf gave his prognosis for the pharma industry at this year’s JP Morgan Healthcare Conference in San Francisco over January 9–12. It gives the FDA greater authority to remove an accelerated approval drug from the market based on poor follow-up safety or efficacy data.

FDA 52

FDA Prescription Medicine Biopharma 52

pharmaphorum

AUGUST 4, 2022

This is due to the specialist nature of roles and the growth and diversification of biopharma, which requires an increasingly sophisticated and skilled workforce. When it comes to recruitment, the pharmaceutical industry should be well placed to capitalise on a society that now has healthcare front of mind. Training and development.

Recruitment 86

Recruitment Pharma Training Pharmaceutical manufacturing 86

Clarivate

DECEMBER 9, 2021

In this episode of Conversations in Healthcare , leaders from Cigna, Henry Ford Health System and eHI discuss how telehealth can help bridge care gaps. Download our new report at right for latest analysis of telehealth’s potential to address healthcare inequities.

Healthcare 52

Healthcare Healthcare Doctors Medicine 52

Clarivate

APRIL 4, 2024

That’s a problem for patients, in whom treatment safety and efficacy can sometimes vary by ethnicity, as well as developers, who are under increasing pressure from regulators like FDA to demonstrate how their products stand to impact diverse populations.

Electronics 52

Electronics Patients Medical FDA 52

Clarivate

OCTOBER 10, 2022

Fruquintinib was well-tolerated, with a safety profile consistent with that previously reported in other studies. The question of which KRAS inhibitor is most effective remains elusive, although being first to market in addition to strong efficacy and safety data could differentiate the more competitive agent. Market impact.

Marketing 52

Marketing Safety Patients Competition 52

Clarivate

NOVEMBER 10, 2022

The purpose of clinical trials is to understand the efficacy and safety of treatments for the patients who need them. In this article, we share how a sponsor partnered with Clarivate to incorporate COAs into clinical trials for alopecia areata. The regulatory landscape around COAs is fast evolving.

Patients 52

Patients Food and Drug Administration FDA Safety 52

Clarivate

MAY 24, 2022

The consortium aims to promote awareness for rare diseases within the healthcare community and general public, address the impending issue of drug availability and improve the quality of life of rare disease patients. Gain access to intelligence on Mainland China’s healthcare market and disease-specific trends. 10] [11] [12].

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Clarivate

NOVEMBER 23, 2023

We have taken a very deliberate approach to our AI technologies, by designing safety, security and truth at its center. The tool then visualizes which indicators are positively, negatively or neutrally affecting a prediction, providing visibility into how the forecast was obtained. “We

Marketing 52

Marketing Management Government Consulting 52

Clarivate

MAY 11, 2023

Over the past five years, healthcare leaders in Mainland China have made significant strides in their efforts to reduce lag time in availability of novel drugs versus western markets. CDE also released guidelines on Clinical trial requirements for overseas drugs.

Marketing 52

Marketing Patients Management Insurance 52

Veeva

JANUARY 30, 2024

Delivering tailored experiences for HCPs in the age of digital engagement When it comes to engaging with healthcare professionals (HCPs), personalization, omnichannel and multichannel strategies are key buzzwords. But what do these really mean, and how can biopharma companies tailor experiences for HCPs and achieve their business objectives?

Biopharma 52

Biopharma Safety Sales CRM 52

pharmaphorum

JANUARY 6, 2023

Veeva’s industry experts share their predictions about how breaking down silos across clinical, regulatory, safety, and quality teams will benefit patients. Emerging and mid-sized companies launching products in Europe are also navigating a healthcare ecosystem that is complex and fragile due to regulatory and cost pressures.

Safety 100

Safety Management Patients Biopharma 100

PM360

SEPTEMBER 28, 2022

Now, as the President of Accord BioPharma , the U.S. The entire premise was that because biosimilars were so new, and there was not a lot of information on the safety and efficacy of those products, customers should be a bit leery prior to jumping on the biosimilar bandwagon. specialty division of Intas Pharmaceuticals, Ltd.,

Competition 98

Competition Marketing Biopharma Manufacturing 98

PM360

JUNE 11, 2022

Only 5% of patients ranked pharma companies as the most trusted player in the healthcare space, according to a 2021 survey of 500 patients from Accenture. Regardless of the tactics and strategies employed, I would encourage more biopharma professionals to get personally involved in patient engagement programs. Rishi Kadiwar.

Patients 59

Patients Pharma Education Media 59

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations.

Government 52

Government Physicians Marketing Biopharma 52

Clarivate

MARCH 17, 2022

How feasible is it to establish a drug’s safety for use in a population that may be unwilling or unable to participate in clinical trials? The health of pregnant people and their fetuses can be compromised if the dose/dosing regimen, safety, and efficacy of treatments used during pregnancy are not established.

Food and Drug Administration 10

Food and Drug Administration Safety FDA Ethics 10

pharmaphorum

SEPTEMBER 28, 2022

A step-by step guide on the benefits, processes, and key considerations involved in the Healthcare Technology Assessment (HTA) Early Scientific Advice (ESA) consultation as part of planning the holistic evidence generation to support the design of an asset. In recent years, the biopharma market has become progressively complex.

Biopharma 52

Biopharma Side effects Consulting Pharmaceutical products 52

World of DTC Marketing

JUNE 8, 2021

They are going to allow Biogen NINE years for follow-up clinical trials in which time our healthcare system is going to pay a TON of money for hope. The swelling was detected with the use of rigorous safety screening, including routine M.R.I.

FDA 207

FDA Food and Drug Administration Patients Biopharma 207

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. Knowledge can change the course of healthcare for all and alter the course of care for individuals in need. Tailored oncology.

Patients 95

Patients Medicine FDA Healthcare 95

European Pharmaceutical Review

DECEMBER 26, 2023

The increasing adoption of technologies promoting safety, efficacy and reduced production costs has been a persistent trend that will continue to benefit the industry and help to treat a broader patient population. million for Hemgenix [AAV5-hFIX-Padua]). million for Hemgenix [AAV5-hFIX-Padua]).

Manufacturing 85

Manufacturing Safety Patients Competition 85

Clarivate

DECEMBER 1, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate experts have selected their top picks from the AHA21 Scientific Sessions. In the following article, we present our analysis of five featured abstracts and our key takeaways for healthcare executives.

Safety 52

Safety Patients Management Marketing 52

Clarivate

OCTOBER 7, 2021

As part of our Drugs to Watch series, which reviews therapies expected to have significant impact on healthcare markets, Clarivate oncology experts sifted through the more than 2,800 abstracts that were accepted for presentation at the ESMO 2021 Virtual Conference and selected their top picks. Context: In August 2021, Merck & Co.

Patients 91

Patients Safety Marketing Physicians 91